GlaxoSmithKline India appoints Sridhar Venkatesh as MD and Vice-President

Sridhar will succeed Annaswamy Vaidheesh, who is set to retire from the company effective March 31, 2020.

Published: 03rd March 2020 02:38 PM | Last Updated: 03rd March 2020 02:38 PM | A+A A-

The GlaxoSmithKline (GSK) logo is seen on top of GSK Asia House in Singapore. (File photo| Reuters)

By PTI

NEW DELHI: Drug firm GlaxoSmithKline Pharmaceuticals on Tuesday said it has appointed Sridhar Venkatesh as managing director & vice president of GSK India, effective April 1, 2020.

He will succeed Annaswamy Vaidheesh, who is set to retire from the company effective March 31, 2020, GlaxoSmithKline Pharmaceuticals said in a statement.

It added that Venkatesh has more than 24 years of diverse experience in pharmaceuticals and healthcare, and has a strong track record of success in multiple roles within GSK. The statement said that he is a registered pharmacist with a master's in pharmacy.

"I warmly welcome Sridhar to lead GSK in our next phase of growth to serve the patients of India. I would also like to take this opportunity to thank Vaidheesh for his leadership during the last 5 years," GlaxoSmithKline Pharmaceuticals Chairperson Renu Karnad said.

Shares of GlaxoSmithKline Pharmaceuticals were trading at Rs 1,316.95 per scrip on the BSE, up 1.26 per cent from its previous close.